Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Arm A:
- People who were diagnosed with anti-GBM disease (a rare autoimmune condition affecting the kidneys and/or lungs) between 1 January 2010 and 31 December 2027
- Records of what treatment was given at the start of the illness must be available
Arm B:
- People who have been diagnosed with anti-GBM disease at any point in time (no date restrictions apply)
- A blood and/or urine sample taken around the time of diagnosis must be available
- Information about whether the person was alive or not at six months after diagnosis must be available
Who may not be able to join:
- There are no specific exclusion criteria listed for either arm of this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +46702871990
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Renal survival at 12 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.